Substituted N-(Benzyl)-N-methyl-2-(1-piperidinyl)ethylamine (BME) and its analogs as new sigma receptor markers: Synthesis, characterization, and in-vivo evaluation

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 42, Issue SUPPL. 1, 1999, Pages

  John, C S ^a   Lim, B B ^a   Vilner, B J ^a   Bowen, W D ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Melanoma and prostate cancer cells; Radioiodination; Sigma receptors; Substituted N (benzyl) N methylethylamines

Indexed keywords

DISEASES;

ETHYLAMINE; IN-VIVO; MELANOMA AND PROSTATE CANCER CELL; MELANOMA CANCER; PROSTATE CANCER CELLS; RADIOIODINATION; SIGMA RECEPTORS; SUBSTITUTED N-(BENZYL)-N-METHYLETHYLAMINE; VIVO EVALUATION;

CANCER CELLS;

ETHYLAMINE; FUNGAL PROTEIN; HALOPERIDOL; IODINE 125; MARKER; PROGESTERONE; SIGMA 1 OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL TISSUE; BINDING SITE; BREAST CARCINOMA; CANCER THERAPY; CONFERENCE PAPER; ENANTIOMER; HUMAN; IMAGING; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; MELANOMA; NONHUMAN; PROSTATE TUMOR; RADIOIODINATION; RAT; STEROL SYNTHESIS; SYNTHESIS; TUMOR CELL LINE;

ANIMALIA;

EID: 0032814809     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)